• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过修饰的硫链丝菌素探索抗菌靶标 MraY 的活性位点。

Exploring the Active Site of the Antibacterial Target MraY by Modified Tunicamycins.

机构信息

Structure, Biophysics and FBLG, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden.

Department of Chemistry and Molecular Biology, University of Gothenburg, Gothenburg, Sweden.

出版信息

ACS Chem Biol. 2020 Nov 20;15(11):2885-2895. doi: 10.1021/acschembio.0c00423. Epub 2020 Nov 9.

DOI:10.1021/acschembio.0c00423
PMID:33164499
Abstract

The alarming growth of antibiotic resistance that is currently ongoing is a serious threat to human health. One of the most promising novel antibiotic targets is MraY (phospho-MurNAc-pentapeptide-transferase), an essential enzyme in bacterial cell wall synthesis. Through recent advances in biochemical research, there is now structural information available for MraY, and for its human homologue GPT (GlcNAc-1-P-transferase), that opens up exciting possibilities for structure-based drug design. The antibiotic compound tunicamycin is a natural product inhibitor of MraY that is also toxic to eukaryotes through its binding to GPT. In this work, we have used tunicamycin and modified versions of tunicamycin as tool compounds to explore the active site of MraY and to gain further insight into what determines inhibitor potency. We have investigated tunicamycin variants where the following motifs have been modified: the length and branching of the tunicamycin fatty acyl chain, the saturation of the fatty acyl chain, the 6″-hydroxyl group of the GlcNAc ring, and the ring structure of the uracil motif. The compounds are analyzed in terms of how potently they bind to MraY, inhibit the activity of the enzyme, and affect the protein thermal stability. Finally, we rationalize these results in the context of the protein structures of MraY and GPT.

摘要

目前正在发生的抗生素耐药性的惊人增长对人类健康构成了严重威胁。最有前途的新型抗生素靶标之一是 MraY(磷酸-MurNAc-五肽转移酶),它是细菌细胞壁合成中的一种必需酶。通过最近在生化研究方面的进展,现在已经获得了 MraY 及其人类同源物 GPT(GlcNAc-1-P-转移酶)的结构信息,这为基于结构的药物设计开辟了令人兴奋的可能性。抗生素化合物衣霉素是 MraY 的天然产物抑制剂,通过与 GPT 结合对真核生物也具有毒性。在这项工作中,我们使用衣霉素和衣霉素的修饰版本作为工具化合物来探索 MraY 的活性位点,并进一步深入了解是什么决定了抑制剂的效力。我们研究了衣霉素变体,其中修饰了以下模体:衣霉素脂肪酸酰链的长度和支化、脂肪酸酰链的饱和度、GlcNAc 环的 6″-羟基和尿嘧啶模体的环结构。根据这些化合物与 MraY 的结合能力、抑制酶活性以及影响蛋白质热稳定性的能力来分析它们。最后,我们根据 MraY 和 GPT 的蛋白质结构来合理化这些结果。

相似文献

1
Exploring the Active Site of the Antibacterial Target MraY by Modified Tunicamycins.通过修饰的硫链丝菌素探索抗菌靶标 MraY 的活性位点。
ACS Chem Biol. 2020 Nov 20;15(11):2885-2895. doi: 10.1021/acschembio.0c00423. Epub 2020 Nov 9.
2
Synthesis and biological evaluation of a MraY selective analogue of tunicamycins.衣霉素的MraY选择性类似物的合成与生物学评价
Nucleosides Nucleotides Nucleic Acids. 2020;39(1-3):349-364. doi: 10.1080/15257770.2019.1649696. Epub 2019 Sep 30.
3
Structural basis for selective inhibition of antibacterial target MraY, a membrane-bound enzyme involved in peptidoglycan synthesis.抗菌靶标 MraY 的选择性抑制的结构基础,MraY 是一种参与肽聚糖合成的膜结合酶。
Drug Discov Today. 2018 Jul;23(7):1426-1435. doi: 10.1016/j.drudis.2018.05.020. Epub 2018 May 18.
4
MraY-antibiotic complex reveals details of tunicamycin mode of action.MraY-抗生素复合物揭示了衣霉素作用模式的细节。
Nat Chem Biol. 2017 Mar;13(3):265-267. doi: 10.1038/nchembio.2270. Epub 2017 Jan 9.
5
Structures of Bacterial MraY and Human GPT Provide Insights into Rational Antibiotic Design.细菌 MraY 和人类 GPT 的结构为合理设计抗生素提供了线索。
J Mol Biol. 2020 Aug 21;432(18):4946-4963. doi: 10.1016/j.jmb.2020.03.017. Epub 2020 Mar 19.
6
Structural insights into inhibition of lipid I production in bacterial cell wall synthesis.细菌细胞壁合成中脂质I生成抑制作用的结构见解
Nature. 2016 May 26;533(7604):557-560. doi: 10.1038/nature17636. Epub 2016 Apr 18.
7
GlcNAc-1-P-transferase-tunicamycin complex structure reveals basis for inhibition of N-glycosylation.GlcNAc-1-P-转移酶-衣霉素复合物结构揭示了抑制 N-糖基化的基础。
Nat Struct Mol Biol. 2018 Mar;25(3):217-224. doi: 10.1038/s41594-018-0031-y. Epub 2018 Feb 19.
8
Phospho-MurNAc-pentapeptide translocase (MraY) as a target for antibacterial agents and antibacterial proteins.磷酸化的胞壁酰五肽转运酶(MraY)作为抗菌剂和抗菌蛋白的作用靶点。
Infect Disord Drug Targets. 2006 Jun;6(2):85-106. doi: 10.2174/187152606784112128.
9
[Bridge between Total Synthesis of Bioactive Natural Products and Development of Drug Leads].[生物活性天然产物全合成与药物先导物开发之间的桥梁]
Yakugaku Zasshi. 2022;142(4):355-363. doi: 10.1248/yakushi.21-00185-2.
10
Tunicamycins from Marine-Derived Inhibit MurNAc-Pentapeptide Translocase in .海洋来源的 Tunicamycins 通过抑制 MurNAc-Pentapeptide 转位酶发挥作用。
Mar Drugs. 2024 Jun 26;22(7):293. doi: 10.3390/md22070293.

引用本文的文献

1
TunR2, a novel mode-of-action tunicamycin-type antibiotic: Pharmacokinetics in C57BL/6 mouse and Holstein cattle.新型作用机制的衣霉素类抗生素TunR2:在C57BL/6小鼠和荷斯坦奶牛中的药代动力学
PLoS One. 2025 Jul 23;20(7):e0327932. doi: 10.1371/journal.pone.0327932. eCollection 2025.
2
Evaluation of the cytotoxicity and antibacterial activity of a synthetic tunicamycin derivative against complex.一种合成衣霉素衍生物对复合物的细胞毒性和抗菌活性评估。
Front Microbiol. 2025 May 15;16:1604400. doi: 10.3389/fmicb.2025.1604400. eCollection 2025.
3
Identifying Opportunity Targets in Gram-Negative Pathogens for Infectious Disease Mitigation.
确定革兰氏阴性病原体中用于减轻传染病的机会靶点。
ACS Cent Sci. 2025 Jan 3;11(1):25-35. doi: 10.1021/acscentsci.4c01437. eCollection 2025 Jan 22.
4
Lipid-Modulated, Graduated Inhibition of N-Glycosylation Pathway Priming Suggests Wide Tolerance of ER Proteostasis to Stress.脂质调节的、对N-糖基化途径引发的渐进性抑制表明内质网蛋白质稳态对压力具有广泛耐受性。
ACS Cent Sci. 2024 Dec 26;11(1):107-115. doi: 10.1021/acscentsci.4c01506. eCollection 2025 Jan 22.
5
The challenges and opportunities of developing small molecule inhibitors of MraY.开发MraY小分子抑制剂的挑战与机遇
Annu Rep Med Chem. 2023;60:1-27. doi: 10.1016/bs.armc.2023.09.005. Epub 2023 Oct 11.
6
The tunicamycin derivative TunR2 exhibits potent antibiotic properties with low toxicity in an in vivo Mycobacterium marinum-zebrafish TB infection model.衣霉素衍生物 TunR2 在体内分枝杆菌-斑马鱼结核感染模型中具有强大的抗生素特性和低毒性。
J Antibiot (Tokyo). 2024 Apr;77(4):245-256. doi: 10.1038/s41429-023-00694-z. Epub 2024 Jan 18.